Pharmacy
HHS says at least 2 million people become infected with antibiotic-resistant bacteria, with 23,000 dying as a result.
Israel-based pharmaceutical company will meet with U.S. FDA to re-submit its marketing application, hopes to launch generic by 2018.
From 2011 to 2015, insurers' payments to hospitals, laboratories, treatment centers and other medical providers for these patients grew from $32 million to $446 million -- a 1,375 percent increase.
Consumers Union wants to know why the cost projections submitted by Anthem and Blue Shield are so much higher than some of their competitors and other industry-wide figures.
While the pharmaceutical industry has historically interacted with patients through clinical trials and marketing efforts, those types of engagement may no longer be enough.
Rising concerns about spending on prescription drugs that treat rare diseases are not justified, according to a new analysis in the journal Health Affairs.
As of July 1, the FDA had 4,036 generic drug applications awaiting approval; median time it takes for the FDA to approve a generic is now 47 months.
Mylan said Monday it will offer a generic version of the life-saving allergy treatment following weeks of criticism over price hike.
The Prescription Drug Monitoring Program aims to combat drug abuse in the state.
Report describes steps states can take to address a number of drug-coverage issues in the commercial insurance market.